Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma. (2022)
Attributed to:
Peta-5: A National Facility for Petascale Data Intensive Computation and Analytics
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2022.868265
PubMed Identifier: 35785153
Publication URI: http://europepmc.org/abstract/MED/35785153
Type: Journal Article/Review
Volume: 12
Parent Publication: Frontiers in oncology
ISSN: 2234-943X